Meet Some of the Physicians
and Cervical Spinal Cord
Injury Patients in the
AST-OPC1 Clinical Trial
 

SCiStar Clinical Trial

Doctors are actively seeking participants for a clinical research study to evaluate three increasing doses of AST-OPC1, an investigational agent for people who recently suffered a cervical (in the neck) spinal cord injury (SCI). All doses of the investigational agent must be administered at a single point in time between 14 and 30 days after injury.

Who is eligible?
Use our interactive prescreener to determine if a loved one or patient may qualify to participate in the SCiStar clinical research study. All candidates must be able to begin study screening within 25 days of their injury.

Use our interactive prescreener to determine if someone you know may qualify to participate in the study or click here to learn more.

Asterias Biotherapeutics Tel: (510) 456-3800